BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 2177368)

  • 1. The action of gliclazide on insulin secretion and insulin sensitivity in non-obese non-insulin dependent diabetic patients.
    Chang TC; Wang LM; Cheng CY; Kuo HF; Liu PC; Ho LT
    Zhonghua Yi Xue Za Zhi (Taipei); 1990 Aug; 46(2):79-85. PubMed ID: 2177368
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of insulin secretion and insulin sensitivity between normal and impaired glucose tolerance subjects with normal fasting plasma glucose.
    Tang KT; Ho LT; Jap TS; Chang TC; Ching KN; Lam HC; Wu MS; Lee SP
    Zhonghua Yi Xue Za Zhi (Taipei); 1990 Aug; 46(2):73-8. PubMed ID: 2177367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of gliclazide treatment on insulin secretion and beta-cell mass in non-insulin dependent diabetic Goto-Kakisaki rats.
    Dachicourt N; Bailbé D; Gangnerau MN; Serradas P; Ravel D; Portha B
    Eur J Pharmacol; 1998 Nov; 361(2-3):243-51. PubMed ID: 9865514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short- and long-term gliclazide effects on pancreatic islet cell function and hepatic insulin extraction in non-insulin-dependent diabetes mellitus.
    Wajchenberg BL; Santomauro AT; Giannella-Neto D; Borghi VC; Porrelli RN
    Diabetes Res Clin Pract; 1992 Aug; 17(2):89-97. PubMed ID: 1425152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gliclazide mainly affects insulin secretion in second phase of type 2 diabetes mellitus.
    Ligtenberg JJ; Reitsma WD; van Haeften TW
    Horm Metab Res; 2001 Jun; 33(6):361-4. PubMed ID: 11456286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of beta-cell function after long-term treatment with either insulin, insulin plus gliclazide or gliclazide in neonatal streptozotocin-induced non-insulin-dependent diabetic rats.
    Kawai K; Suzuki S; Murayama Y; Watanabe Y; Yamashita K
    Diabetes Res Clin Pract; 1991 Jul; 12(3):163-72. PubMed ID: 1832376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Features of insulin secretion and insulin resistance in newly diagnosed type 2 diabetes of different body mass indices].
    An YL; Gao Y; Zhu Q; Ning G; Jia WP; Huang Q; Xu W; Li CJ; Zhou ZG; Shi BY; Shan ZY; Chen LL; Xu ZR; Wang H; Yan L; Zhong HJ; Ji QH; Li H; Xue YM; Zhing MX; Gu W; Guo XH; Gao LL; Hong J; Liu F; Zou DJ; Li YB; Zhang XY; Li Z; Guo G; Zhao XJ; Wu HN; Wang YZ; Zhao WG; Zhang SL; Wu J; Zhang NY; Yang FY; Zhang Y; Zhou XR; Ren YZ; Li GW
    Zhonghua Yi Xue Za Zhi; 2009 Apr; 89(16):1117-21. PubMed ID: 19595144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin action and insulin secretion in newly diagnosed type 2 diabetic patients.
    Tzeng TF; Chen JH; Hsiao PJ; Hsieh MC; Shin SJ
    Kaohsiung J Med Sci; 2001 Sep; 17(9):468-74. PubMed ID: 11842650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of sulphonylurea therapy on skeletal muscle glycogen synthase activity and insulin secretion in newly presenting type 2 (non-insulin-dependent) diabetic patients.
    Johnson AB; Argyraki M; Thow JC; Jones IR; Broughton D; Miller M; Taylor R
    Diabet Med; 1991 Apr; 8(3):243-53. PubMed ID: 1828740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolonged sulfonylurea administration decreases insulin resistance and increases insulin secretion in non-insulin-dependent diabetes mellitus: evidence for improved insulin action at a postreceptor site in hepatic as well as extrahepatic tissues.
    Mandarino LJ; Gerich JE
    Diabetes Care; 1984; 7 Suppl 1():89-99. PubMed ID: 6376034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of gliclazide on plasma insulin, intact and 32/33 split proinsulin in South Asian subjects with Type 2 diabetes mellitus.
    Ammari F; Davies MJ; Koppiker N; Gregory R; Burden AC
    Diabet Med; 1999 Feb; 16(2):142-6. PubMed ID: 10229308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of weight loss and reduced hyperglycemia on the kinetics of insulin secretion in obese non-insulin dependent diabetes mellitus.
    Gumbiner B; Polonsky KS; Beltz WF; Griver K; Wallace P; Brechtel G; Henry RR
    J Clin Endocrinol Metab; 1990 Jun; 70(6):1594-602. PubMed ID: 2189885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gliclazide potentiates suppression of hepatic glucose production in non-insulin-dependent diabetic patients.
    Riccio A; Lisato G; de Kreutzenberg SV; Marchetto S; Turrin M; Tiengo A; Del Prato S
    Metabolism; 1996 Oct; 45(10):1196-202. PubMed ID: 8843172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of 6-month gliclazide treatment on insulin release and sensitivity to endogenous insulin in NIDDM: role of initial continuous subcutaneous insulin infusion-induced normoglycemia.
    Della Casa L; del Rio G; Glaser B; Cerasi E
    Am J Med; 1991 Jun; 90(6A):37S-45S. PubMed ID: 1872303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute and chronic effects of dexfenfluramine on glucose and insulin response to intravenous glucose in diabetic and non-diabetic obese subjects.
    Glaser B; Raveh Y; Norynberg C; Berry E; Lavielle R; Nathan C; Cerasi E
    Diabetes Res; 1992; 19(4):165-76. PubMed ID: 1343113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Laparoscopic sleeve gastrectomy for diabetes treatment in nonmorbidly obese patients: efficacy and change of insulin secretion.
    Lee WJ; Ser KH; Chong K; Lee YC; Chen SC; Tsou JJ; Chen JC; Chen CM
    Surgery; 2010 May; 147(5):664-9. PubMed ID: 20004451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated 1-hour postload plasma glucose levels identify subjects with normal glucose tolerance but impaired β-cell function, insulin resistance, and worse cardiovascular risk profile: the GENFIEV study.
    Bianchi C; Miccoli R; Trombetta M; Giorgino F; Frontoni S; Faloia E; Marchesini G; Dolci MA; Cavalot F; Cavallo G; Leonetti F; Bonadonna RC; Del Prato S;
    J Clin Endocrinol Metab; 2013 May; 98(5):2100-5. PubMed ID: 23539736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of Diamicron on the secretion and action of insulin.
    Chiasson JL; Hamet P; Verdy M
    Diabetes Res Clin Pract; 1991; 14 Suppl 2():S47-51. PubMed ID: 1794265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rosiglitazone and pioglitazone similarly improve insulin sensitivity and secretion, glucose tolerance and adipocytokines in type 2 diabetic patients.
    Miyazaki Y; DeFronzo RA
    Diabetes Obes Metab; 2008 Dec; 10(12):1204-11. PubMed ID: 18476983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Secretion and hepatic extraction of insulin after weight loss in obese noninsulin-dependent diabetes mellitus.
    Henry RR; Brechtel G; Griver K
    J Clin Endocrinol Metab; 1988 May; 66(5):979-86. PubMed ID: 3283164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.